Preferential crystallization (PC) is a process to separate enantiomers. The efficiency of seeded, isothermal PC was enhanced using tailor-made additives to inhibit the crystallization of the counter-enantiomer. The inhibition of D-asparagine (D-Asn) monohydrate using D-glutamic acid (D-Glu) and D-aspartic acid (D-Asp) as additives in PC was investigated by comparing the purity, yield, and particle size distribution after PC of L-Asn·H2O from DL-Asn·H2O. The amount of pure L-Asn·H2O solid product that can be produced before crystallization of the counter-enantiomer is higher when using the additives D-Asp and D-Glu. However, the crystal size of L-Asn·H2O increases faster in PC without additives than in PC with additives. This means that the ...
Chiral molecules can be a particular challenge when used in drugs because of the existence of their ...
The recognition of differences in the pharmacological activity of enantiomeric molecules has induced...
Acknowledgments: Funding is acknowledged from the European Research Council under the European Union...
Preferential Crystallization (PC) is a popular process to separate enantiomers, however the nucleati...
Because of its simplicity and cost-effectiveness, preferential crystallization (PC) can be considere...
Enantiomers are chiral molecules (i.e. they are mirror-images of each other). They have identical ph...
The application of enantioseparation methods alone can only yield up to 50% of the desired chiral pr...
Separating enantiomers is of persistent importance due to the possible differences in biological eff...
The separation of enantiomers is a field of growing interest in the pharmaceutical industry as well ...
Driven by the policy of regulatory authorities such as US Food and Drug Administration and the EU Co...
The application of enantioseparation methods alone can only yield up to 50% of the desired chiral pr...
Two enantiomers of the same chiral active pharmaceutical ingredients (APIs) often have different pha...
The experimental realization of a continuous preferential crystallization process, consisting of two...
Usually racemic mixtures of chrial substances are produced in chemical industry although in most cas...
The separation of chiral compounds is of large interest since most of the (bio-)organic molecules ar...
Chiral molecules can be a particular challenge when used in drugs because of the existence of their ...
The recognition of differences in the pharmacological activity of enantiomeric molecules has induced...
Acknowledgments: Funding is acknowledged from the European Research Council under the European Union...
Preferential Crystallization (PC) is a popular process to separate enantiomers, however the nucleati...
Because of its simplicity and cost-effectiveness, preferential crystallization (PC) can be considere...
Enantiomers are chiral molecules (i.e. they are mirror-images of each other). They have identical ph...
The application of enantioseparation methods alone can only yield up to 50% of the desired chiral pr...
Separating enantiomers is of persistent importance due to the possible differences in biological eff...
The separation of enantiomers is a field of growing interest in the pharmaceutical industry as well ...
Driven by the policy of regulatory authorities such as US Food and Drug Administration and the EU Co...
The application of enantioseparation methods alone can only yield up to 50% of the desired chiral pr...
Two enantiomers of the same chiral active pharmaceutical ingredients (APIs) often have different pha...
The experimental realization of a continuous preferential crystallization process, consisting of two...
Usually racemic mixtures of chrial substances are produced in chemical industry although in most cas...
The separation of chiral compounds is of large interest since most of the (bio-)organic molecules ar...
Chiral molecules can be a particular challenge when used in drugs because of the existence of their ...
The recognition of differences in the pharmacological activity of enantiomeric molecules has induced...
Acknowledgments: Funding is acknowledged from the European Research Council under the European Union...